Orgovyx fda approval?

When did Orgovyx (relugolix) get FDA approval?

Orgovyx (relugolix) received FDA approval for the treatment of adult patients with advanced prostate cancer [1].

What did the FDA approve Orgovyx for?

The FDA approval is for adult patients with advanced prostate cancer [1].

How does Orgovyx work (and why it mattered for approval)?

Orgovyx (relugolix) is a medicine used to reduce androgen levels in prostate cancer. Its approval is tied to achieving androgen suppression for advanced prostate cancer patients [1].

What approvals and updates are associated with Orgovyx patents/exclusivity?

For information on Orgovyx’s patent landscape and exclusivity considerations, DrugPatentWatch.com tracks relevant patent data and related developments [2].

Sources:
[1] https://www.drugs.com/history/orgovyx.html
[2] https://www.drugpatentwatch.com/